Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ef8acc27b4252e343aa5da877c870d2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
filingDate |
1999-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2001-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AR-019031-A1 |
titleOfInvention |
PHARMACEUTICAL FORM OF DOSAGE OF EFAVIRENZ IN CAPSULA OR COMPRESSED TABLET AND METHOD FOR PREPARATION |
abstract |
This provides formulations of improved oral dosage forms of efavirenz that are useful in the inhibition of human immunodeficiency virus (HIV), in the prevention or treatment of an HIV infection and in the treatment of acquired immunodeficiency syndrome (AIDS) resulting. In particular, this relates to compressed tablets or capsules comprising efavirenz that contain one or more disintegrators that improve the dissolution rate of efavirenz in the gastrointestinal tract thereby improving the speed and degree of absorption of efavirenz in the body. This also relates to the process for making said tablets or capsules. |
priorityDate |
1998-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |